Abstract
Radiation therapy (RT) is administered with varying intentions, sometimes even several times in the same or in different body areas, to over 50% of patients with neoplastic conditions. Numerous techniques are available to patients in the clinical evolution of mycosis fungoides (MF), and there are several indications for radiation therapy (RT). RT as a skin-directed therapy is very widely used in these patients, either alone or in conjunction with other therapies. The application of RT, a tried-and-true therapy that improves MF patients’ quality of life and treatment, can be encouraged by a multidisciplinary approach and an understanding of current methods and action mechanisms.
Reference29 articles.
1. Kumari S, Mukherjee S, Sinha D, et al. Immunomodulatory effects of radiotherapy. Int J Mol Sci 2020; 21:8151.
2. Hoppe RT, Cox RS, Fuks Z, et al. Electron-beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 1979;63:691-700.
3. Lin SH, Ye R, Wang Y. Preclinical Strategies for Testing of Targeted Radiosensitizers. In: Willers, H., Eke, I. (eds.) Molecular targeted radiosensitizers. Cancer Drug Discovery and Development. Humana, Cham; 2020.
4. Kim E. Mogamulizumab for CTCL: targeted therapy and immunotherapy crossing paths. Dermatol World Insights Inquiries 2020;2.
5. Mukherjee S, Abdisalaam S, Bhattacharya S, et al. Mechanistic link between DNA damage sensing, repairing and signaling factors and immune signaling. Adv Protein Chem Struct Biol 2019;115:297-324.